Planetpharma Pharmaceutical Import Profile — France (DGFT 2022–2026)

Name: Planetpharma Pharmaceutical Import Records from India — 5 Products, $8.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Planetpharma — Pharmaceutical Importer Profile (2026) | 5 Products, $8.2M Trade | TransData Nexus

Planetpharma

Pharmaceutical Importer · France · Advanced Antibiotics Focus · $8.2M Total Trade · DGFT Verified

Planetpharma is a pharmaceutical importer based in France with a total trade value of $8.2M across 5 products in 3 therapeutic categories. Based on 186 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Planetpharma sources from 44 verified Indian suppliers, with Macleods Pharmaceuticals Limited accounting for 34.6% of imports.

Planetpharma — Import Portfolio & Supplier Network

Planetpharma import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Planetpharma?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Macleods Pharmaceuticals Limited	$19.6M	909	34.6%
Ipca Laboratories Limited	$15.8M	625	27.8%
Troikaa Pharmaceuticals Limited

What Formulations Does Planetpharma Import?

Formulation	Value	Ships
Rabemac dsr 20MG/30MG gel	$673.0K	16
Azicure 500MG cpr b/3 (azithromycin TAB	$550.0K	11
Drugs and pharmaceuticals harmless	$486.6K	36
Harmless medicines zerodol 100MG	$455.1K	11
Accuzon 1g SOL INJ b/1 (ceftriaxone	$400.0K	8
Azicure 200MG/5ML SUSP oral f/15ML(azithromycin suspension 200MG/5ML)	$395.9K	8
Harmless medicines zerodol p	$354.6K	8
Harmless medicines zerodol cr 200MG	$345.6K	14
Harmless medicines pantonex dr 40MG	$328.7K	11
Trenaxa 500MG cpr b/30 (tranexamic	$308.2K	7
Dynapar diclofenac sodium and paracetamol tablets other details as per document &	$300.0K	6
Accuzon 1g(ceftriaxone for injection USP 1g)	$300.0K	6
Harmless medicines:laridox 525MG	$290.9K	6
Harmless medicines stericef 1g	$287.9K	7
Cefolac 200MG cpr pell b/8 (cefixime TAB	$285.9K	6

Planetpharma imports 1,837 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Azithromycin	Antibiotics	$2.5M	49	1.3%	6
2	Cefixime	Advanced Antibiotics	$2.3M	46	1.3%	9
3	Ceftriaxone	Advanced Antibiotics	$1.8M	49	0.6%	16
4	Domperidone	Gastrointestinal	$1.6M	31	5.2%	3
5	Ornidazole	Advanced Antibiotics	$185.1K	11	1.0%	12

Planetpharma imports 5 pharmaceutical products across 3 categories into France totaling $8.2M.

Planetpharma — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Planetpharma is a French pharmaceutical importer and wholesaler headquartered in Le Grand-Quevilly, Normandy, France. Established on February 1, 1992, the company operates under the legal form of a Société Anonyme (SA) with a Board of Directors. It specializes in the wholesale distribution of pharmaceutical products, serving as a critical link in the supply chain between manufacturers and healthcare providers. (entreprises.lagazettefrance.fr)

As a subsidiary of the UbiPharm group, Planetpharma plays a pivotal role in the pharmaceutical distribution network, particularly focusing on the import and export of pharmaceutical products. The company manages the distribution of medications for over 100 pharmaceutical laboratories to 150 wholesaler-distributor customers across 23 countries in Africa and France’s overseas departments and territories.

2Distribution Network

Planetpharma operates two storage platforms in France, covering a total area of 25,000 square meters with a combined storage capacity of 37,000 pallets. These facilities are equipped with automated systems that perform storage and preparation operations efficiently, ensuring compliance with good distribution practices. The strategic location of these warehouses near the ports of Rouen and Le Havre facilitates efficient logistics and distribution, both within France and to international markets.

3Industry Role

In France's pharmaceutical supply chain, Planetpharma functions primarily as a wholesale distributor and pharmaceutical depot. It imports pharmaceutical products from various countries, including India, and distributes them to a network of customers, including wholesalers and healthcare providers. Additionally, Planetpharma is responsible for managing regulatory affairs, such as the registration and maintenance of marketing authorizations for drugs, ensuring compliance with French regulations.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Planetpharma

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Planetpharma's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 100% of its imports from India. This indicates a strategic focus on a limited range of products, potentially to leverage volume discounts and streamline operations. The significant import values of these products—Azithromycin ($2.5M), Cefixime ($2.3M), Ceftriaxone ($1.8M), Domperidone ($1.6M), and Ornidazole ($185K)—suggest a stable and ongoing relationship with Indian suppliers. The consistent import volumes over the years further reflect the stability and reliability of these supplier relationships.

2Supply Chain Resilience

Planetpharma's supply chain resilience is bolstered by its diversified supplier base, comprising 44 unique Indian suppliers. This diversification mitigates risks associated with dependency on a single supplier. The company's dual storage platforms, equipped with automated systems, enhance operational efficiency and continuity. However, the concentration of imports in a few key products may expose the company to risks related to market fluctuations or supply disruptions in these specific product categories.

3Strategic Implications

Importing Pharmaceuticals into France — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for France

1Regulatory Authority & Framework

In France, the primary regulatory authority overseeing pharmaceutical imports is the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM). Key legislation governing pharmaceutical imports includes the Public Health Code and the European Union's directives on medicinal products. The marketing authorization pathway for Indian generics involves obtaining a Marketing Authorization (MA) from the ANSM, which requires compliance with EU standards for quality, safety, and efficacy.

2Import Licensing & GMP

Import licensing requirements in France stipulate that pharmaceutical products must be authorized for sale within the EU. Good Manufacturing Practice (GMP) certificates recognized by the European Union, such as EU GMP, WHO GMP, or PIC/S, are mandatory for imported products. Additionally, wholesale distribution authorization is required, ensuring that distributors adhere to stringent standards for storage, handling, and distribution of pharmaceutical products.

3Quality & Labeling

Planetpharma — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Planetpharma's focus on importing advanced antibiotics, general antibiotics, and gastrointestinal products aligns with the high demand for these medications in France. The substantial import values of Azithromycin, Cefixime, and Ceftriaxone indicate a strategic emphasis on these therapeutic areas, likely driven by their critical role in treating a wide range of infections and gastrointestinal disorders. This product strategy positions Planetpharma to meet the essential healthcare needs of the French population.

2Sourcing Profile

Planetpharma's sourcing strategy centers on generic drugs, primarily from India, leveraging the country's robust pharmaceutical manufacturing capabilities. The company's preference for finished pharmaceutical formulations, such as tablets, capsules, syrups, and injections, reflects a focus on ready-to-market products that meet EU regulatory standards. India's established reputation for producing high-quality generics makes it a strategic partner for Planetpharma's procurement needs.

3Market Positioning

Based on its product mix, Planetpharma serves multiple segments of the French pharmaceutical market, including retail pharmacies, hospitals, and wholesale distribution channels. The company's emphasis on essential antibiotics and gastrointestinal medications positions it as a key supplier to healthcare providers and distributors, ensuring the availability of critical treatments across various healthcare settings.

Seller's Guide — How to Become a Supplier to Planetpharma

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Planetpharma, particularly in the therapeutic areas of advanced antibiotics and gastrointestinal products. Gaps in Planetpharma's current sourcing may exist in specialized formulations or emerging treatments, presenting avenues for Indian exporters to introduce innovative products. Establishing relationships with Planetpharma could lead to increased market access and distribution opportunities within France and its overseas territories.

2Requirements & Qualifications

Indian exporters aiming to supply Planetpharma and the French market must obtain GMP certifications recognized by the EU, such as EU GMP, WHO GMP, or PIC/S. Products must comply with French labeling requirements, including French language labeling and serialization mandates. Additionally, obtaining a Marketing Authorization from the ANSM is essential, ensuring that products meet the quality, safety, and efficacy standards required for sale in France.

3How to Approach

Frequently Asked Questions — Planetpharma

What products does Planetpharma import from India?

Planetpharma imports 5 pharmaceutical products across 3 categories. Top imports: Azithromycin ($2.5M), Cefixime ($2.3M), Ceftriaxone ($1.8M), Domperidone ($1.6M), Ornidazole ($185.1K).

Who supplies pharmaceuticals to Planetpharma from India?

Planetpharma sources from 44 verified Indian suppliers. The primary supplier is Macleods Pharmaceuticals Limited (34.6% of imports, $19.6M).

What is Planetpharma's total pharmaceutical import value?

Planetpharma's total pharmaceutical import value from India is $8.2M, based on 186 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Planetpharma focus on?

Planetpharma imports across 3 categories. The largest: Advanced Antibiotics (51.4%), Antibiotics (29.8%), Gastrointestinal (18.8%).

Get Full Planetpharma Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.